Idiopathic intracranial hypertension: a possible association with Imatinib

Authors

  • Anja M. Palmowski-Wolfe University of Basel, Department of Ophthalmology, Basel
  • Eva Pape University Basel, Department of Neurology, Basel
  • Thomas Baumann Neurozentrum Bern, Bern
  • Margarita G. Todorova University of Basel, Department of Ophthalmology, Basel

DOI:

https://doi.org/10.16964/er.v1i1.54

Keywords:

idiopathic intracranial hypertension, glivec, imatinib.

Abstract

Idiopathic intracranial hypertension (IIH) is characterized by an increased intracranial pressure in the absence of a tumor and in the absence of a venous thrombosis. Associated risk factors include obesity and several medications such as tetracyclines. We report a 60-year-old patient who developed IIH under treatment with imatinib. To our knowledge such a possible connection has not been reported in the literature, even though intracranial hypertension is now listed as a rare possible side effect of treatment with imatinib in the Swiss List of Medications Arzneimittelkompendium. It remains to be seen, if further case reports will support this observation.

Downloads

Published

2011-11-11

Issue

Section

Case Reports